| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $121,725,374 ) (Continued on the next page) |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 001 | 2 | NIH | 6/12/2025 | -$23,789 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 000 | 2 | NIH | 2/14/2025 | $44,074 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HS029001 | Pain, Multimorbidity, Opioid-Drug Interactions and Risk for Opioid Use Disorder or Overdose in Older Adults | 000 | 3 | AHRQ | 2/7/2025 | $194,958 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA266402 | Improving Treatment Selection in Advanced Ovarian Cancer | 001 | 4 | NIH | 5/23/2025 | $55,735 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA266402 | Improving Treatment Selection in Advanced Ovarian Cancer | 000 | 4 | NIH | 2/18/2025 | $501,610 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA261068 | Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | 006 | 6 | NIH | 5/22/2025 | $50,804 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA261068 | Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | 005 | 6 | NIH | 2/28/2025 | $408,041 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AI181224 | Surface dependent inhibition of Mycobacterium abscessus by Pseudomonas aeruginosa | 000 | 2 | NIH | 2/28/2025 | $190,969 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AG082113 | Targeting specific MicroRNA to alleviate Alzheimer’s Disease pathobiology | 001 | 3 | NIH | 6/17/2025 | $54,836 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AG082113 | Targeting specific MicroRNA to alleviate Alzheimer’s Disease pathobiology | 000 | 3 | NIH | 3/6/2025 | $616,903 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AI185617 | RNA epigenetic modifications in SARS-CoV-2 | 000 | 1 | NIH | 1/31/2025 | $582,618 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM153349 | Envelope biogenesis in Gram-negative bacteria | 001 | 2 | NIH | 4/29/2025 | $379,420 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AI191986 | Function of HIV-1 Env cytoplasmic tail domain | 000 | 1 | NIH | 1/28/2025 | $229,163 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | U01AI173348 | Structure, function, and antigenicity of emerging henipavirus surface glycoproteins | 003 | 3 | NIH | 5/30/2025 | $597,757 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL161618 | Development and validation of cardiovascular MRI techniques on a low-field, ultra-wide bore system to assess patients with severe obesity | 000 | 4 | NIH | 1/28/2025 | $505,319 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM155038 | The metabolic clock as a regulator of cell fate decision | 000 | 2 | NIH | 6/17/2025 | $372,588 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K01AR080833 | Sensory neuron-skin interaction in health and disease | 000 | 3 | NIH | 1/28/2025 | $125,442 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL171220 | Mitochondrial deubiquitinase USP30 regulates cell metabolism-mediated miRNA biogenesis and microvascular inflammation | 000 | 1 | NIH | 1/27/2025 | $678,803 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL171164 | Hypoxia-induced aberrant lactate generation and shuttling serves as a direct signal to promote pro-fibrotic fibroblast phenotypes | 000 | 1 | NIH | 1/27/2025 | $786,147 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168728 | Atrial and blood JNK in Postoperative AF | 000 | 9 | NIH | 1/27/2025 | $616,206 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM139482 | Advanced NMR, computational, and hybrid methods for metabolomics | 001 | 5 | NIH | 5/28/2025 | $373,632 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32DC021844 | Patient-Reported Benefits of Cochlear Implant Listening Configurations | 000 | 2 | NIH | 5/6/2025 | $87,611 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32DC021844 | Patient-Reported Benefits of Cochlear Implant Listening Configurations | 001 | 2 | NIH | 6/12/2025 | $1,224 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL131941 | Role of Cytoglobin in the Regulation of Vascular Tone | 000 | 7 | NIH | 11/7/2024 | $695,427 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA278052 | Addressing Disparities in Outcomes of Screening for Colorectal Cancer in Community-Based Settings | 000 | 3 | NIH | 4/14/2025 | $604,360 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DE033906 | The oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes | 000 | 2 | NIH | 5/20/2025 | $626,952 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R61AG081982 | Development of an online mindfulness training program for adults with subjective cognitive decline | 002 | 2 | NIH | 6/20/2025 | $41,254 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R61AG081982 | Development of an online mindfulness training program for adults with subjective cognitive decline | 001 | 2 | NIH | 4/25/2025 | $464,114 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01NS130308 | Mechanisms underlying regulation of injured axons in CNS autoimmunity | 000 | 2 | NIH | 11/20/2024 | $469,016 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R34DA061589 | Brief Digitally-Enhanced Intervention for Managing Emotional Pain and Reducing Alcohol Use during Medication for OUD | 000 | 2 | NIH | 6/3/2025 | $393,750 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH135117 | Progression of Social Cognitive Deficits in Mid- and Late-Life Schizophrenia Spectrum Disorders | 000 | 2 | NIH | 1/14/2025 | $752,698 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K12TR004546 | CTSA K12 Program at The Ohio State University | 000 | 2 | NIH | 6/11/2025 | $877,377 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R34EY035783 | Identification of School-age Eye conditions Evaluation (ISEE) | 000 | 2 | NIH | 3/28/2025 | $236,650 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM151155 | Interrogating function, regulation, and interactions in a clade of prevalent human gut microbes | 000 | 3 | NIH | 5/23/2025 | $381,621 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37CA259642 | Time-varying relationships between built environment factors, colon and rectum cancer prognosis, and survival | 001 | 4 | NIH | 5/22/2025 | $55,717 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37CA259642 | Time-varying relationships between built environment factors, colon and rectum cancer prognosis, and survival | 000 | 4 | NIH | 4/16/2025 | $501,450 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37AI118852 | TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES | 000 | 10 | NIH | 6/5/2025 | $452,849 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA285726 | CD200R blockade for cancer immunotherapy | 000 | 2 | NIH | 6/16/2025 | $673,569 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168045 | Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics | 000 | 2 | NIH | 12/6/2024 | $671,704 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA280007 | A sensitivity analysis framework for generalizing randomized clinical trial results in the presence of unmeasured treatment effect modifiers | 000 | 2 | NIH | 11/26/2024 | $80,739 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL139006 | Biophysical Modulation of Cardiac Ion Channels by MicroRNA | 002 | 7 | NIH | 5/27/2025 | $651,378 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL164443 | SLC29A3 lysosomal transporter in hematopoietic homeostasis and disease | 000 | 2 | NIH | 2/27/2025 | $393,750 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH085739 | Timing, reward processing and choice | 004 | 13 | NIH | 4/29/2025 | $0 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH085739 | Timing, reward processing and choice | 005 | 14 | NIH | 5/28/2025 | $416,176 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH085739 | Timing, reward processing and choice | 000 | 13 | NIH | 12/3/2024 | $78,063 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH129589 | Prenatal neuroinflammation: maternal microbiome contributions and behavioral consequences | 000 | 4 | NIH | 2/13/2025 | $463,764 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01NS104332 | Determining the role of lipid droplets and their therapeutic potential in glioblastoma | 001 | 8 | NIH | 6/27/2025 | $544,245 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA248741 | Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer | 001 | 5 | NIH | 5/29/2025 | $74,183 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA248741 | Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer | 000 | 5 | NIH | 2/17/2025 | $667,657 |
|
